A new cell proliferating marker: Cytosolic thymidine kinase as compared to Proliferating Cell Nuclear Antigen in patients with colorectal carcinoma

Anticancer Research

Volumn 20, Issue 6 C, 2000, Pages 4815-4820

  Wu, J ^a   Mao, Y ^a   He, L ^a   Wang, N ^a   Wu, C ^a   He, Q ^a   Skog, S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Colorectal carcinoma; Cytosolic thymidine kinase (TK1); Immunohistochemistry; Proliferating cell nuclear antigen (PCNA)

Indexed keywords

CYCLINE; THYMIDINE KINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CELL LABELING; CELL PROLIFERATION; COLON ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOSOL; ENZYME MECHANISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM ADENOMA;

ADENOCARCINOMA, PAPILLARY; ADENOMA; ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA; CARCINOMA, SIGNET RING CELL; CELL DIVISION; COLORECTAL NEOPLASMS; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PROLIFERATING CELL NUCLEAR ANTIGEN; REFERENCE VALUES; THYMIDINE KINASE;

EID: 0034491670     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Indirect immunofluorescence studies of proliferating cell nuclear antigen in nucleoli of human tumor and normal tissues
2. Cell proliferation and its evaluation in the colorectal mucosa: Effect of ethanol
3. Detection of apoptotic cells in human colorectal cancer by two different in situ methods: Antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) methods
4. Proliferative activity in colonic adenomas as a predictor of metachronous adenomas as assessed by proliferating cell nuclear antigen immunohistochemistry
5. p53 and PCNA expression in advanced colorectal cancer; response to chemotherapy and long-term prognosis
6. Analyses of PCAN and AgNOR on adevanced colorectal cancer as predictive indicators of the prognosis
7. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas
8. Cell proliferation kinetics are abnormal in transitional mucosa adjacent to colorectal carcinoma
9. DNA flow cytometry, P53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues
10. Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classifications for colorectal cancer
11. PCNA defined proliferative activity of epithelial tumor cells in adenomas of the colon
12. Clinical, histopathological, cytogenetic and prognostic differences between mucinous and nonmucinous colorectal adenocarcinomas
13. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is marker for cell proliferation
14. Regulation of thymidine kinase enzyme level in serum-stimulated mouse 3T6 fibroplasis
15. Regulation of human thymidine kinase during the cell cycle
16. Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumors
17. Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells
18. Serum thymidine kinase in colorectal neoplasia
19. Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication
20. Thymidine kinase transcription is regulated at G1/S phase by a complex that contains retinoblastoma-like protein and a cdc 2 kinase
21. Increased expression of p34cdc2 and its activity in human gastric and colonic carcinomas
22. Concurrent overexpression of cyclin Dl and cyclin-dependent kinase 4(Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients